13F

Stock

Abvc Biopharma, Inc.

ABVC · held by 14 managers

Reported value

$1.82M

Holders

14

+1 new · −0 exited

Holders’ est. mark

−$160

Price effect on 1 books still in the name

Largest holder

$613.3K

Vanguard

Notable conviction

Share of each notable manager’s 13F book.

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
Vanguard287.9K$613.3KHeld
GEODE CAPITAL MANAGEMENT, LLC202.4K$431.1KHeld
Renaissance Technologies114.3K$243.4KHeld
State Street72.8K$155.1KHeld
BlackRock, Inc.56.4K$120.2KHeld
Citadel55.5K$118.3KHeld
NORTHERN TRUST CORP32.1K$68.3KHeld
XTX Topco Ltd11.3K$24KHeld
JANE STREET GROUP, LLC10.9K$23.1KHeld
MORGAN STANLEY5.17K$11KNew
Tower Research Capital LLC (TRC)3.19K$6.8KHeld
UBS Group AG2.59K$5.51KHeld
SIMPLEX TRADING, LLC196$417Held
BANK OF AMERICA CORP /DE/189$402−$160Cut−$130

Positions as of Q4 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.